EVH241220P45000
- 0.00
- 0.000.00%
Evolent Health Newsroom
J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $15
Express News | Evolent Health Inc : JP Morgan Cuts Target Price to $15 From $45
High Quality 'SMID-cap' Stocks With Cyclical Exposure – MS
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode
Oppenheimer Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $28
Evolent Health Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $28
Evolent Health (NYSE:EVH) Seems To Use Debt Quite Sensibly
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Engaged Capital Adds BlackLine, Exits Shake Shack, Others in Q3
Express News | Evolent Health Inc : Piper Sandler Cuts Target Price to $18 From $38
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $21
RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $20
Evolent Health Price Target Maintained With a $20.00/Share by RBC Capital
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $19 to $36
RBC Capital Sticks to Its Buy Rating for Evolent Health (EVH)
Evolent Health Shares Are Trading Higher. Barclays Maintained an Overweight Rating on the Stock.
Evolent Health Is Maintained at Overweight by Barclays
Evolent Health Analyst Ratings
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $24